Skip to main content
. 2019 Nov 5;10(60):6403–6417. doi: 10.18632/oncotarget.27237

Figure 6. Heatmap of drug response in HB-214.

Figure 6

(A) Cell proliferation in response to 72-hour drug treatment. (B) Combination index of volasertib and SN38 drug treatments. White dotted line denotes clinically achievable concentration ranges. N = 4.